Ingo Weigmann
Impact in
-
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Blood Pressure and Hypertension Studies
Papers in
-
- Cardiac electrophysiology and arrhythmias 1
- Blood Pressure and Hypertension Studies 1
- Antiplatelet Therapy and Cardiovascular Diseases 1
-
- Angiogenesis and VEGF in Cancer 1
- Co-authors
- Frank Pistrosch (2 shared papers)M Hanefeld (2 shared papers)Andreas L. Birkenfeld (2 shared papers)Jan Sradnick (1 shared paper)Bernhard Schipp (1 shared paper)Stefan R. Bornstein (1 shared paper)Dorothea Schipp (1 shared paper)Elena Henkel (1 shared paper)
- Journals
- PLoS ONE (1 paper)Diabetologia (1 paper)International Journal of Clinical Pharmacology and Therapeutics (1 paper)PubMed (1 paper)
- Partner nations
- GermanyUnited Kingdom
In The Last Decade
Ingo Weigmann
4 papers receiving 28 citations
Peers
Comparison fields: 5 of 29
- Internal Medicine 7
- Cardiology and Cardiovascular Medicine 17
- Hematology 4
- Endocrine and Autonomic Systems 2
- Neurology 2
Countries citing papers authored by Ingo Weigmann
This map shows the geographic impact of Ingo Weigmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Weigmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Weigmann more than expected).
Fields of papers citing papers by Ingo Weigmann
This network shows the impact of papers produced by Ingo Weigmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Weigmann. The network helps show where Ingo Weigmann may publish in the future.
Co-authors
The 17 scholars most cited alongside Ingo Weigmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 15 | |
| 2 | 2017 | 11 | |
| 3 | [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo]. | 1998 | 3 |
| 4 | 2005 | 1 |
About Ingo Weigmann
Ingo Weigmann is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Nephrology, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 4 papers that have together received 30 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (1 paper), Analytical Methods in Pharmaceuticals (1 paper), Retinal Diseases and Treatments (1 paper), Renal function and acid-base balance (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Blood Pressure and Hypertension Studies (1 paper), Antiplatelet Therapy and Cardiovascular Diseases (1 paper) and Retinal Imaging and Analysis (1 paper). The work is most often cited by research in Internal Medicine (7 citations), Cardiology and Cardiovascular Medicine (17 citations), Hematology (4 citations), Endocrine and Autonomic Systems (2 citations) and Neurology (2 citations). Ingo Weigmann has collaborated with scholars based in Germany and United Kingdom. Frequent co-authors include Frank Pistrosch, M Hanefeld, Andreas L. Birkenfeld, Jan Sradnick, Bernhard Schipp, Stefan R. Bornstein, Dorothea Schipp, Elena Henkel, Dirk Sandner and Katrin Engelmann. Their work appears in journals such as PLoS ONE, Diabetologia, International Journal of Clinical Pharmacology and Therapeutics and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.